Download PDF
Planta Med 2006; 72(9): 807-813
DOI: 10.1055/s-2006-946638
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Extracts from Pygeum africanum and Other Ethnobotanical Species with Antiandrogenic Activity

Sonja Schleich1 , Maria Papaioannou2 , Aria Baniahmad2 , 3 , Rudolf Matusch1
  • 1Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany
  • 2Genetisches Institut, Justus-Liebig-Universität Giessen, Giessen, Germany
  • 3Department of Biochemistry, University Kuopio, Finland
Further Information

Publication History

Received: January 25, 2006

Accepted: April 27, 2006

Publication Date:
19 June 2006 (online)

Also available at
    Permissions and Reprints

Abstract

Extracts from Pygeum africanum, Serenoa repens and Cucurbita pepo are used in the treatment of benign prostatic hyperplasia (BPH) and prostate cancer (PCa). The activity of the androgen receptor (AR) is known to control growth of the prostate. Here, we examined extracts of these plants for their antiandrogenic activity using an AR responsive reporter gene assay for drug discovery. A selective dichloromethane extract from the stem barks of Pygeum africanum revealed the highest antiandrogenic effect. Bioactivity-directed fractionation of this extract led to the isolation of N-butylbenzenesulfonamide (NBBS) indicating that extracts of the stem bark of P. africanum harbour androgen antagonistic activity. This compound may provide a novel approach for the prevention and treatment of BPH and human PCa.

Abbreviations

AR:human androgen receptor

BPH:benign prostate hyperplasia

C. pep:Cucurbita pepo

IPSS:international prostate symptom score

NBBS:N-butylbenzenesulfonamide

P. africanum:Pygeum africanum

PCa:prostate cancer

QoL:quality of life

R1881:methyltrienolone

RLU:relative light units

S. repens:Serenoa repens

Key words

Antiandrogenic activity - Pygeum africanum - Rosaceae - Serenoa repens - Arecaceae - Cucurbita pepo - Cucurbitaceae - N-butylbenzenesulfonamide - prostate hyperplasia

References

  • 1 Shah U S, Getzenberg R H. Fingerprinting the diseased prostate, associations between BPH and prostate cancer.  J Cell Biochem. 2004;  91 161-9
    CrossrefPubMedSearch in Google Scholar
  • 2 Levin R M, Das A K. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens .  Urol Res. 2000;  28 201-9
    CrossrefPubMedSearch in Google Scholar
  • 3 Gonzalgo M L, Isaacs W B. Molecular pathways to prostate cancer.  J Urol. 2003;  170 2444-52
    CrossrefPubMedSearch in Google Scholar
  • 4 Bombardelli E, Morazzoni P. Prunus Africana (Hook. f.) Kalkm.  Fitoterapia. 1997;  68 205-18
    PubMedSearch in Google Scholar
  • 5 Andro M C, Riffaud J P. Pygeum africanum extract for the treatment of patients with benign prostatic hyperplasia: A review of 25 year of published experience.  Curr Ther Res Clin Exp. 1995;  56 796-817
    CrossrefPubMedSearch in Google Scholar
  • 6 Yablonsky F, Nicolas V, Riffaud J P, Bellamy F. Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts.  J Urol. 1997;  157 2381-7
    CrossrefPubMedSearch in Google Scholar
  • 7 Chatelain C, Autet W, Brackman F. Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open label extension.  Urology. 1999;  54 473-8
    CrossrefPubMedSearch in Google Scholar
  • 8 Ishani A, MacDonald R, Nelson D, Rutks I, Wilt T J. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.  Am J Med. 2000;  109 654-64
    CrossrefPubMedSearch in Google Scholar
  • 9 Dreikorn K. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia.  World J Urol. 2002;  19 426-35
    PubMedSearch in Google Scholar
  • 10 Breza J, Dzurny O, Borowka A, Hanus T, Petrik R, Blane G. et al . Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.  Curr Med Res Opin. 1998;  14 127-39
    PubMedSearch in Google Scholar
  • 11 Bombardelli E, Morazzoni P. Serenoa repens (Bartram) J.K. Small.  Fitoterapia. 1997;  68 99-113
    PubMedSearch in Google Scholar
  • 12 Al-Shukri S H, Deschaseaux P, Kuzmin I V, Amdiy R R. Early urodynamic effects of the lipido-sterolic extract of Serenoa repens (Permixon®) in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.  Prostate Cancer Prostatic Dis. 2000;  3 195-9
    CrossrefPubMedSearch in Google Scholar
  • 13 Gerber G S, Kuznetsov D, Johnson B C, Burstein J D. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.  Urology. 2001;  58 960-4
    CrossrefPubMedSearch in Google Scholar
  • 14 Debruyne F, Koch G, Boyle P, Da Silva F C, Gillenwater J G, Hamdy F C. et al . Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.  Eur Urol. 2002;  41 497-507
    CrossrefPubMedSearch in Google Scholar
  • 15 Bombardelli E, Morazzoni P. Cucurbita pepo L.  Fitoterapia. 1997;  68 291-302
    PubMedSearch in Google Scholar
  • 16 Longo R, Tira S. Constituents of Pygeum africanum Bark.  Planta Med. 1981;  42 195-6
    PubMedSearch in Google Scholar
  • 17 McClure M W. An overview of holistic medicine and complementary and alternative medicine for the prevention and treatment of BPH, prostatitis, and prostate cancer.  World J Urol. 2002;  20 273-84
    CrossrefPubMedSearch in Google Scholar
  • 18 Awad A B, Burr A T, Fink C S. Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells.  Prostaglandins Leukot Essent Fatty Acids. 2005;  72 219-26
    CrossrefPubMedSearch in Google Scholar
  • 19 Kim K K, Kang J G, Moon S, Kang K Y. Isolation and identification of antifungal N-butylbenzensulfonamide produces by Pseudomonas sp. AB2.  J Antibiot. 2000;  53 131-6
    PubMedSearch in Google Scholar
  • 20 Gast A, Schneikert J, Cato A C. N-terminal sequences of the human androgen receptor in DNA binding and transrepressing functions.  J Steroid Biochem Mol Biol. 1998;  65 117-23
    CrossrefPubMedSearch in Google Scholar
  • 21 Dotzlaw H, Moehren U, Mink S, Cato A C, Iniguez Lluhi J A, Baniahmad A. The amino terminus of the human AR is target for corepressor action and antihormone agonism.  Mol Endocrinol. 2002;  16 661-73
    CrossrefPubMedSearch in Google Scholar
  • 22 Dotzlaw H, Papaioannou M, Moehren U, Claessens F, Baniahmad A. Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor.  Mol Cell Endocrinol. 2003;  213 79-85
    CrossrefPubMedSearch in Google Scholar
  • 23 Fourneau C, Hocquemiller R, Cavé A. Triterpenes from Prunus africana bark.  Phytochemistry. 1996;  42 1387-89
    CrossrefPubMedSearch in Google Scholar
  • 24 Bach D. Placebokontrollierte Langzeittherapiestudie mit Kürbissamenextrakt bei BPH-bedingten Miktionsbeschwerden.  Urologe B. 2000;  40 437-43
    CrossrefPubMedSearch in Google Scholar
  • 25 Klippel K P, Hiltl D M, Schipp B, the German BPHP study g roup. Randomized double-blinded placebo controlled trial to evaluate the efficacy of β-sitosterol (phytosterol) in patients with obstructive and irritative symptoms due to BPH.  Brit J Urol. 1997;  80 427-32
    PubMedSearch in Google Scholar
  • 26 Schleich S, Papaioannou M, Baniahmad A, Matusch R. Activity-guided isolation of an antiandrogenic compound of Pygeum africanum. Planta Med, in press
  • 27 Huppert N, Würtele M, Hahn H H. Determination of the plasticizer N-butylbenzenesulfonamide and the pharmaceutical Ibuprofen in wastewater using solid phase microextraction (SPME).  Fresenius J Anal Chem. 1998;  362 529-36
    CrossrefPubMedSearch in Google Scholar
  • 28 Poliakova O V, Lebedev A T, Hänninen O. Organic pollutants in snow of urban and rural Russia and Finland.  Environ Toxicol Chem. 2000;  75 181-94
    PubMedSearch in Google Scholar

Aria Baniahmad

Institute of Human Genetics and Anthropology

University of Jena

Kollegiengasse 10

07745 Jena

Germany

Phone: +49-3641-935-524

Fax: +49-3641-934-706

Email: aban@mti.uni-jena.de